首页 > 市场调查报告书 > 製药

基因治疗学和RNAi

市场调查报告书

商品编码

1603365

转染技术市场规模、份额、成长分析、按产品、按方法、按应用、按最终用户、按地区 - 行业预测，2024-2031 年

Transfection Technologies Market Size, Share, Growth Analysis, by Product (Kits, Equipment), By Method (Physical, Biochemical), By Application (Biomedical Research, Therapeutic Delivery), By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年11月28日 | 出版商:

SkyQuest | 英文 183 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球转染技术市场规模将为11亿美元，从2023年的12亿美元成长到2031年的26.9亿美元，在预测期间（2024-2031年）预计复合年增长率为9.4%。

由于慢性病盛行率上升和对个人化药物的需求不断增加，生物製药市场正在经历显着增长。这项扩张的核心是转染技术在生物製药开发和製造中的关键作用。基因治疗领域正在快速发展，旨在对抗遗传疾病和癌症，并且越来越依赖病毒传递技术来确保标靶基因传递。持续的研究和开发产生了创新的转染试剂、设备和方法，可提高转染效率，同时最大限度地减少细胞毒性作用并改善细胞迁移。分子和细胞生物学研究活动的活性化推动了这种创新的激增，我敦促您投资用于药物发现和功能基因组学的转染技术。竞争格局的特点是主要企业寻求透过卓越的产品性能、可靠性、易用性、定价和客户环境来使自己脱颖而出。此外，法律规范显着影响市场动态，特别是在基因治疗和临床应用方面。随着产业的发展，技术进步、研究投资和监管合规性的相互作用将继续塑造生物製药产业的成长轨迹，为整个价值链的相关人员带来广阔的机会。

市场概况
物理转染
- 电穿孔
- 基因枪转染/基因枪
- 显微注射
- 其他物理转染方法
基于生物化学的转染
- 脂转染
- 磷酸钙转染
- 阳离子聚合物转染
- DEAE-聚葡萄糖转染
- 磁力辅助转染
- 树状聚合物介导的转染
基于病毒载体的转染
共转染

转染技术市场规模：依应用/复合年增长率（2024-2031）

市场概况
生物医学研究
- 基因/蛋白质表现研究
- 癌症研究
- 基因改造模型
实施治疗
- 生物製药
- 电免疫疗法
- 化疗
蛋白质生产
细胞微阵列

转染技术市场规模：最终用户复合年增长率（2024-2031）

市场概况
製药和生物技术公司
CRO 和 CDMO
学术研究所
其他的

转染技术市场法规/复合年增长率（2024-2031）

北美洲
- 美国
- 加拿大
欧洲
- 英国
- 德国
- 西班牙
- 法国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲

竞争资讯

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市场趋势
公司市场占有率分析（2023）
主要企业简介
- 公司简介
- 产品系列分析
- 按公司分公司分類的股份分析
- 收益与前一年同期比较（2021-2023）

主要企业简介

Thermo Fisher Scientific Inc.（US）
Bio-Rad Laboratories, Inc.（US）
QIAGEN（Netherlands）
Merck KGaA（Germany）
Sartorius AG（Polyplus）（Germany）
Lonza（Switzerland）
F. Hoffmann-La Roche Ltd（Switzerland）
Agilent Technologies, Inc.（US）
MaxCyte（US）
Revvity（US）
Takara Bio Inc.（Japan）
Promega Corporation（US）
Danaher Corporation（US）
BOC Sciences（US）
RJH BIOSCIENCES（Canada）
Synvolux（Netherlands）
Altogen Biosciences（US）
BioIVT（US）
Incella GmbH（Germany）
InvivoGen（France）

结论和建议

简介目录

Product Code: SQMIG15A2450

Global Transfection Technologies Market size was valued at USD 1.10 Billion in 2022 and is poised to grow from USD 1.2 Billion in 2023 to USD 2.69 Billion by 2031, growing at a CAGR of 9.4% in the forecast period (2024-2031).

The biopharmaceutical market is witnessing significant growth driven by the rising prevalence of chronic diseases and an increasing demand for personalized medicines. Central to this expansion is the pivotal role of transfection technologies in the development and manufacturing of biopharmaceuticals. The gene therapy sector is experiencing rapid advancements aimed at addressing genetic disorders and cancer, with a growing reliance on viral delivery technologies to ensure targeted gene delivery. Continuous research and development are yielding innovative transfection reagents, devices, and methodologies, enhancing transfection efficiency while minimizing cytotoxic effects and improving cell migration. This surge in innovation is fueled by heightened research activity in molecular and cell biology, prompting academic institutions, research laboratories, and pharmaceutical companies to invest in transfection technologies for drug discovery and functional genomics. The competitive landscape is characterized by leading companies striving for differentiation through superior product performance, reliability, user-friendliness, pricing, and customer support. Moreover, regulatory frameworks significantly influence market dynamics, particularly concerning gene therapy and clinical applications. As the industry evolves, the interplay between technological advancements, investment in research, and regulatory compliance will continue to shape the growth trajectory of the biopharmaceutical sector, signaling promising opportunities for stakeholders across the value chain.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transfection Technologies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transfection Technologies Market Segmental Analysis

Global Transfection Technologies Market is segmented by Product, Method, Application, End User and region. Based on Product, the market is segmented into Kits, Equipment. Based on Method, the market is segmented into Physical transfection (Electroporation, Biolistic transfection/ gene guns, Microinjection, Other physical transfection methods), Biochemical-based transfection (Lipofection, Calcium phosphate transfection, Cationic polymer transfection, DEAE-dextran transfection, Magnet-assisted transfection, Dendrimer-mediated transfection), Viral-vector based transfection, Cotransfection. Based on application, the market is segmented into Biomedical research (Gene and protein expression studies, Cancer research, Transgenic models), Therapeutic delivery (Biotherapeutics, Electroimmunotherapy, Electrochemotherapy), Protein production, Cell-based microarrays. Based on end user, the market is segmented into Pharmaceutical and biotechnology companies, CROs and CDMOs, Academic and research institutes, Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Transfection Technologies Market

The Global Transfection Technologies market is significantly driven by the increasing introduction of innovative products. Co-transfection, which entails the simultaneous introduction of multiple nucleic acids into a eukaryotic cell, exemplifies this trend, showcasing a variety of methodologies including the use of plasmid DNA, combinations of siRNA and plasmid DNA, and multiple miRNAs within a single cell. This technique aims to integrate several foreign genes into host cells, facilitating applications such as the creation of viral or hybrid viral constructs that incorporate multiple plasmid DNA segments. Notable examples include the generation of lentivirus utilizing diverse plasmids-transfer, envelope, and packaging vectors-within HEK293 cells, highlighting the potential advancements in gene delivery systems.

Restraints in the Global Transfection Technologies Market

Restraints in the Global Transfection Technologies market include the escalating costs and complexities associated with certain sterilization methods. Techniques that require specialized equipment or proprietary components can be financially burdensome and challenging to execute. The initial investment, combined with ongoing maintenance expenses and the necessity for specialized expertise, may pose significant barriers, particularly for academic researchers and small biotechnology firms that often operate within tight budget constraints. As a result, these financial and operational hurdles can limit access to essential transfection technologies, potentially stifling innovation and progress within the field.

Market Trends of the Global Transfection Technologies Market

The global transfection technologies market is witnessing a significant trend toward the adoption of advanced delivery systems for nucleic acids. Innovations such as lipid nanoparticles, polymer-based carriers, and viral vectors are increasingly preferred due to their superior transfection efficiency, enhanced cellular targeting, and minimized cytotoxic effects compared to traditional methods. This shift is particularly evident in sectors such as gene therapy, drug delivery, and genome editing, where precision and safety are paramount. The ongoing research in biomedical applications underscores the urgency to design effective viral technologies, signaling a robust demand that is reshaping the landscape of transfection technologies worldwide.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Value Chain Analysis
Case Study Analysis
PESTEL Analysis
Macro-Economic Indicators
Market Attractiveness Index

Global Transfection Technologies Market Size by Product & CAGR (2024-2031)

Market Overview
Kits
Equipment

Global Transfection Technologies Market Size by Method & CAGR (2024-2031)

Market Overview
Physical transfection
- Electroporation
- Biolistic transfection/ gene guns
- Microinjection
- Other physical transfection methods
Biochemical-based transfection
- Lipofection
- Calcium phosphate transfection
- Cationic polymer transfection
- DEAE-dextran transfection
- Magnet-assisted transfection
- Dendrimer-mediated transfection
Viral-vector based transfection
Cotransfection

Global Transfection Technologies Market Size by Application & CAGR (2024-2031)

Market Overview
Biomedical research
- Gene and protein expression studies
- Cancer research
- Transgenic models
Therapeutic delivery
- Biotherapeutics
- Electroimmunotherapy
- Electrochemotherapy
Protein production
Cell-based microarrays.

Global Transfection Technologies Market Size by End User & CAGR (2024-2031)

Market Overview
Pharmaceutical and biotechnology companies
CROs and CDMOs
Academic and research institutes
Other

Global Transfection Technologies Market Size & CAGR (2024-2031)

North America, (Product, Method, Application, End User)
- US
- Canada
Europe, (Product, Method, Application, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Product, Method, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Product, Method, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa, (Product, Method, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Polyplus) (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MaxCyte (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revvity (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BOC Sciences (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RJH BIOSCIENCES (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synvolux (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Altogen Biosciences (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioIVT (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Incella GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
InvivoGen (France)
- Conclusio Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments